Skip to main content
Top
Published in: Neurological Sciences 6/2012

01-12-2012 | Case Report

Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration

Authors: Heyun Kim, Kon Chu, Keun-Hwa Jung, Soon-Tae Lee, Jeong-Min Kim, Sang Kun Lee

Published in: Neurological Sciences | Issue 6/2012

Login to get access

Abstract

We describe a 47-year-old woman who presented with palinopsia and subacute altered mental change after cefditoren pivoxil administration. The patient showed characteristic clinical manifestations of hypocarnitinemia, which affected her state of consciousness and she had radiologic findings that revealed metabolic encephalopathy with cytotoxic edema in the right occipital area and intracranial hemorrhages in right occipital and left frontal areas. Follow-up imaging after oral carnitine supplementation demonstrated complete resolution of the bilateral frontal subcortical T2 high-intensity lesions. Carnitine deficiency due to cefditoren pivoxil treatment may present as metabolic encephalopathy in adults. This possibility should be considered with the differential diagnosis of encephalopathies, and carnitine levels should be checked in patients treated with cefditoren pivoxil.
Literature
1.
go back to reference Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B, Jodal U (1989) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2(8661):469–473PubMedCrossRef Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B, Jodal U (1989) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2(8661):469–473PubMedCrossRef
2.
go back to reference Reuter SE, Evans AM, Chace DH, Fornasini G (2008) Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann ClinBiochem. 45(Pt 6):585–592 Reuter SE, Evans AM, Chace DH, Fornasini G (2008) Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann ClinBiochem. 45(Pt 6):585–592
3.
go back to reference Virmani A, Binienda Z (2004) Role of carnitine esters in brain neuropathology. Mol Aspects Med 25(5–6):533–549PubMedCrossRef Virmani A, Binienda Z (2004) Role of carnitine esters in brain neuropathology. Mol Aspects Med 25(5–6):533–549PubMedCrossRef
4.
go back to reference Schäfer J, Reichmann H (1990) Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study. J Neurol 237(3):213–215PubMedCrossRef Schäfer J, Reichmann H (1990) Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study. J Neurol 237(3):213–215PubMedCrossRef
5.
go back to reference Winter SC, Szabo-Aczel S, Curry CJ, Hutchinson HT, Hogue R, Shug A (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141(6):660–665PubMed Winter SC, Szabo-Aczel S, Curry CJ, Hutchinson HT, Hogue R, Shug A (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141(6):660–665PubMed
6.
go back to reference Ito T, Sugiyama N, Kobayashi M et al (1995) Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid containing prodrugs. Tohoku J Exp Med 175:43–53PubMedCrossRef Ito T, Sugiyama N, Kobayashi M et al (1995) Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid containing prodrugs. Tohoku J Exp Med 175:43–53PubMedCrossRef
7.
go back to reference Lheureux PE, Penaloza A, Zahir S, Gris M (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity-what is the evidence? Crit Care 9(5):431–440PubMedCrossRef Lheureux PE, Penaloza A, Zahir S, Gris M (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity-what is the evidence? Crit Care 9(5):431–440PubMedCrossRef
8.
go back to reference Averbuch-Heller L, Ben-Hur T, Reches A (1994) Valproate encephalopathy and hypocarnitinaemia in diabetic patients. J Neurol 241:567–569PubMedCrossRef Averbuch-Heller L, Ben-Hur T, Reches A (1994) Valproate encephalopathy and hypocarnitinaemia in diabetic patients. J Neurol 241:567–569PubMedCrossRef
9.
10.
go back to reference Todesco L, Bodmer M, Vonwil K, Häussinger D, Krähenbühl S (2009) Interaction between pivaloylcarnitine and l-carnitine transport into L6 cells over expressing hOCTN2. ChemBiol Interact 180(3):472–477CrossRef Todesco L, Bodmer M, Vonwil K, Häussinger D, Krähenbühl S (2009) Interaction between pivaloylcarnitine and l-carnitine transport into L6 cells over expressing hOCTN2. ChemBiol Interact 180(3):472–477CrossRef
11.
go back to reference Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G (2007) Brain magnetic resonance in the diagnostic evaluation of mitochondrial. EncephalopathiesBiosci Rep 27:69–85CrossRef Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G (2007) Brain magnetic resonance in the diagnostic evaluation of mitochondrial. EncephalopathiesBiosci Rep 27:69–85CrossRef
Metadata
Title
Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration
Authors
Heyun Kim
Kon Chu
Keun-Hwa Jung
Soon-Tae Lee
Jeong-Min Kim
Sang Kun Lee
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 6/2012
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-0939-7

Other articles of this Issue 6/2012

Neurological Sciences 6/2012 Go to the issue